Venous thromboembolism after joint arthroplasty: where do we stand with aspirin?
EFORT Open Reviews · 01.11.2026 · 11 (11) · 1228-1235
DOI: 10.1530/eor-2026-0129 ↗Kurz gefasst
Fachartikel in der Zeitschrift EFORT Open Reviews, online erschienen am 02.11.2026. Verfasst von Andrea Zampoli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Operative Research Unit of Orthopaedic and Trauma Surgery, Università Campus Bio-Medico di Roma , Rome, Italy. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Venous thromboembolism prophylaxis after total joint arthroplasty remains heterogeneous, particularly regarding the role of aspirin within modern fast-track pathways. Although aspirin is widely used in North American arthroplasty practice, European guidelines remain more conservative and often provide limited or non-operational recommendations for its use after total hip and knee arthroplasty. Contemporary evidence supports aspirin as a viable prophylactic option in selected patients, with potential advantages related to its safety profile, cost, ease of administration and reduced treatment burden. The clinical role of aspirin should be interpreted within a risk-stratified framework that accounts for thromboembolic risk, bleeding risk, surgical complexity, early mobilization and duration of prophylaxis. Available evidence, including recent randomized data, supports aspirin-based prophylaxis in appropriately selected patients, both as part of sequential strategies and, increasingly, as monotherapy within contemporary fast-track pathways. This scoping review synthesizes current guideline-level evidence and contemporary clinical data to clarify practical considerations for agent selection, dosing, duration and aspirin-based prophylaxis after total joint arthroplasty.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Operative Research Unit of Orthopaedic and Trauma Surgery, Università Campus Bio-Medico di Roma , Rome, Italy.
- Research Unit of Orthopaedic and Trauma Surgery, Fondazione Policlinico Universitario Campus Bio-Medico , Rome, Italy.
- International Joint Center, Acibadem University Hospital , Istanbul, Turkey.
- Department of Orthopedic Surgery, NSU , Miami, Florida, USA.
- Joint Reconstruction Research Center, Tehran University of Medical Sciences (TUMS) , Tehran, Iran.
ORCID-Profile: Andrea Zampoli, Ali Parsa, Seyed Mohammad Javad Mortazavi, Rocco Papalia, Javad Parvizi
Zitieren
APA
Zampoli, A., Dikmen, G., Parsa, A., Mortazavi, S. M. J., Papalia, R., & Parvizi, J. (2026). Venous thromboembolism after joint arthroplasty: where do we stand with aspirin?. EFORT Open Reviews, 11(11), 1228-1235. https://doi.org/10.1530/eor-2026-0129
Vancouver
Zampoli A, Dikmen G, Parsa A, Mortazavi SMJ, Papalia R, Parvizi J. Venous thromboembolism after joint arthroplasty: where do we stand with aspirin?. EFORT Open Reviews. 2026;11(11):1228-1235. doi:10.1530/eor-2026-0129
BibTeX
@article{Zampoli2026,
author = {Zampoli, Andrea and Dikmen, Goksel and Parsa, Ali and Mortazavi, Seyed Mohammad Javad and Papalia, Rocco and Parvizi, Javad},
title = {Venous thromboembolism after joint arthroplasty: where do we stand with aspirin?},
journal = {EFORT Open Reviews},
year = {2026},
volume = {11},
number = {11},
pages = {1228--1235},
doi = {10.1530/eor-2026-0129}
}
EUVIMED